Introduction
Congenital anomalies are also known as birth defects or congenital malformations. They are important causes of infant and childhood deaths, chronic illness and disability. Congenital anomalies can be defined as structural or functional anomalies (for example, metabolic disorders) that occur during intrauterine life and can be identified prenatally, at birth, or sometimes may only be detected later in infancy. Due to these anomalies, an estimated 303 000 newborns die within 4 weeks of birth every year, worldwide. 1 Congenital anomalies can contribute to long-term disability, which may have significant impacts on individuals, families, health-care systems, and societies. The most common, severe congenital anomalies are heart defects, neural tube defects and Down syndrome.
Although congenital anomalies may be the result of one or more genetic, infectious, nutritional or environmental factors, it is often difficult to identify the exact causes. Some congenital anomalies can be prevented. Few methods include vaccination, adequate intake of folic acid or iodine through fortification of staple foods or supplementation, and adequate antenatal care. https://doi.org/10.18231/j.ijogr.2020.015 2394-2746/© 2020 Innovative Publication, All rights reserved. 71
Materials and Methods
A Retrospective cohort study which was conducted in Department of Obstetrics and Gynaecology, Mahatma Gandhi Medical College and Research Institute, Pondicherry over a 3 year period from September 2016 to September 2019. Antenatal women diagnosed with congenital anomalies by imaging who delivered in our hospital were included in this study. Different types of anomalies were classified and risk factors leading to them were assessed. Variables like maternal age, parity, consanguinity, abortions or intrauterine deaths, sibling with malformation, nutrition, addictions, family history of congenital anomalies, conceived after infertility treatment, maternal diabetes, infections, fever and drugs were evaluated. Gestational age at which delivery had occurred, sex, weight of the baby and NICU admission were also noted. Data was collected and analysed by SPSS software.
Results
During the study period out of 6134 deliveries, 140 babies had congenital anomalies leading to a prevalence of 2.28%. 80 of these babies did not have lethal anomalies and survived but medical termination of pregnancy was required in 60 cases. Of the 140 babies with congenital anomalies 77 were males whereas 63 were females. In this study the prevalance of congenital anomalies was found to be higher in males at 55%. 55 babies were born to primigravida mothers with a prevalence of 39.3%.
As shown in Table 1 , majority of congenital anomalies was seen in the younger age group between 21-25 years (42.1%). Consanuguinity was present only in 27.86% cases. Only 7.86% had history of recurrent abortions or history of IUFD. 5.71% cases had received treatment for primary infertility. Only 55.71% cases had history of folic acid intake. 74.3% had normal BMI. Only 5% had family history of congenital anomalies. 51.43% of congenital anomalous babies crossed 28 weeks of gestation. 25% of cases had history of Gestational Diabetes Mellitus and were on treatment with insulin.72.14% had normal vaginal delivery whereas 27.86% of cases required Caesarean section. 60.71% had a birth weight less than 2.5 kg. (Table 2) Majority of congenital anomalies affected the Central Nervous system accounting for 28.5% of cases followed by gastrointestinal system (20.71%) & musculskeletal system (20%). (Table 3 ) Anomalies involving genitourinary system were also common accounting for 11.43% cases. 3.57% cases involved cardiovascular system of which the most common anomaly was Tetrology of Fallot. Syndromic babies accounted for 5% cases. Colloidon baby was the commonest congenital anomaly involving the skin. Sirenomelia (Mermaid baby), Poland syndrome, Pierre 
Discussion
The percentage of congenital anomalies in this study was 2.28%. This is similar to other studies by Shamma M et al 2 and Shatanik Sarkar et al 3 where the incidence was 2-3%, 2.2% respectively. But global estimates suggest that congenital anomalies affect 2 -3% of births. 4 Assuming 2% birth prevalence, and 25,595,000 births in 2013, an estimated 511,900 births may have been affected with a congenital anomaly in India. 5 In our study majority of congenital anomalies were seen between 20-30 years which is in contrast to the study by Kokate et al 6 where maternal age >30 was the most important risk factor. 42.9% of anomalies in our study were lethal anomalies whereas in the study by Kokate et al 80% of the babies were compatible with life and 20% were non compatible. In our study incidence of congenital anomalies was more in multipara with a prevalence of 60.71%. This is in accordance with the study by Pandala P et al 7 where higher percentage of congenital anomalies was seen in birth order more than 4. In our study 51.43% of anomalous babies crossed 28 weeks of gestation which is similar to the study by Kokate et al where the incidence was 72%.
The most common congenital anomaly in our study was central nervous system anomaly followed by gastrointestinal and musculoskeletal anomaly. This is in contast to the study by Vinodh L et al 8 where the most common anomaly detected was musculoskeletal anomaly (24%) followed by CNS and genitourinary system anomalies. In the study by Kokate et al craniospinal anomalies was commonest (44%) followed by musculoskeletal (30%) and syndromic anomalies (12%).
Conclusion
The incidence of congenital anomalies in India is around 2.5%. 9 These congenital anomalies account for 13-16% of neonatal deaths and 8-15% of perinatal deaths. 10, 11 Preconceptional counselling, folic acid intake and avoiding consanguineous marriages can help in reducing the incidence of congenital anomalies. Proper detection of congenital anomalies by 18 weeks will help patients in planning termination before 20 weeks according to MTP Act. Genetic counselling also plays a role in patients with repeated anomalous babies or syndromic babies.
In utero fetal surgeries have advanced to such an extent reducing neonatal mortality and improving outcome. In places where the patient population are educated and necessary precautions are already taken, the best we can do is to reduce the morbidity and mortality associated with such congenital anomalies.
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